Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
The purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this crohn's disease clinical trial in Boston, MA
If you're searching for crohn's disease treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.